Related Experiment Video

Updated: Jul 10, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Patent ductus arteriosus: lack of evidence for common treatments

Carl L Bose1, Matthew M Laughon

  • 1Carl L Bose, Division of Neonatal-Perinatal Medicine, CB#7596, UNC Hospital, Chapel Hill, NC 27599-7596, USA cbose@med.unc.edu

Archives of Disease in Childhood. Fetal and Neonatal Edition
|October 24, 2007
PubMed

Insights

Patent ductus arteriosus (PDA) closure in premature infants is debated. This review examines spontaneous closure rates, risks of persistent PDA, and treatment effects, supporting a conservative approach.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology

Background:

  • Patent ductus arteriosus (PDA) is frequent in extremely premature infants, particularly those with lung disease.
  • Treatments to close PDA are common, but their risks versus benefits remain unclear.
  • Current research has not definitively answered whether PDA treatment benefits outweigh risks.

Purpose of the Study:

  • To review the evidence regarding patent ductus arteriosus (PDA) in premature infants.
  • To evaluate the benefits and risks associated with PDA treatments.
  • To support a conservative approach to PDA management.

Main Methods:

  • Review of spontaneous closure rates of the ductus arteriosus.
  • Assessment of adverse effects associated with persistent PDA.
  • Analysis of benefits and risks of PDA closure treatments.

Main Results:

  • The article supports a restrained approach to PDA treatment.
  • Spontaneous closure rates, adverse effects of persistent PDA, and treatment risks are key considerations.
  • Evidence suggests benefits of treatment may not consistently outweigh risks.

Conclusions:

  • A conservative approach to managing patent ductus arteriosus (PDA) in premature infants is advocated.
  • Further research is needed to clarify the optimal management strategy for PDA.
  • Individualized patient assessment is crucial when considering PDA interventions.

More Related Videos

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...